We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

By LabMedica International staff writers
Posted on 27 Mar 2024

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. More...

Other transmission modes include blood transfusions, organ transplants, and shared needles or syringes contaminated with infected blood. Although the largest burden of malaria is in sub-Saharan Africa, Southeast Asia, the Eastern Mediterranean, the Western Pacific, and the Americas also report many cases and deaths. Because of the risk of malaria transmission, many potential blood donors who have traveled to or lived in malaria-endemic areas are currently ineligible to donate blood. The existing methods for detecting malaria in blood, such as microscopy and serology, lack the necessary sensitivity to ensure the safety of blood transfusions. Now, the first FDA-approved molecular test to screen U.S. blood donors for malaria marks a significant advancement in maintaining a safe global blood supply.

Roche (Basel, Switzerland) has obtained FDA approval for the cobas Malaria test for use on the cobas 6800/8800 Systems. This test enables healthcare providers to minimize the risks of malaria transmission through blood transfusion by identifying blood units infected with malaria. It screens for the five primary species of Plasmodium parasites that cause malaria in humans, enhancing both the safety and availability of blood supplies. Designed for screening blood, organs, and tissue donations, the cobas Malaria test is a qualitative in vitro test that detects Plasmodium RNA and DNA in whole blood samples from individual donors. It is essential to note that the test is not for diagnosing Plasmodium infections, nor is it applicable to cord blood samples or cadaveric blood specimens. Utilizing the Roche Whole Blood Collection Tube, the test streamlines the workflow by allowing direct blood draws from donors and immediate processing on the cobas 6800/8800 Systems.

“As the first FDA-approved blood screening test for malaria, this represents an important step forward in safeguarding the global supply of donated blood," said Matt Sause, CEO of Roche Diagnostics. “The approval of cobas Malaria represents a significant advancement in malaria detection, offering healthcare professionals a reliable tool for donor screening and improving the safety of patients worldwide.”


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Capillary Blood Collection Tube
IMPROMINI M3
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.